University of Kentucky Law Expert Available to Address Recent Proposed National Opioid Settlements with Drug Companies
University of Kentucky
The University of Kentucky, the University of Tennessee, Knoxville and the U.S. Army Combat Capabilities Development Command’s Army Research Laboratory have announced a five-year, $50 million collaboration directed toward improving manufacturing capabilities in the U.S.
A recently published study co-authored by University of Kentucky Sanders-Brown Center on Aging researcher Justin Miller, Ph.D., identifies 11 rare candidate variants for Alzheimer’s disease. Researchers found 19 different families in Utah that suffered from Alzheimer’s disease more frequently than what is considered normal.
UK HealthCare, UofL Health, the Kentucky Department for Public Health’s Heart Disease and Stroke Prevention Program (KHDSP), and other state partners have been awarded the prestigious Paul Coverdell National Acute Stroke Program Grant by the Centers for Disease Control and Prevention. This $1.8 million grant aims to optimize both stroke prevention among those at high risk as well as improve the care and outcomes for stroke patients throughout Kentucky.
A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by elevated blood pressure at night.
For nearly a year, we relied on masks to help prevent the spread of COVID-19. Now, many are removing the facial coverings, but that doesn’t mean it will be easy to shed the anxiety that accompanies a global pandemic. If you’re having difficulty coping with this added stress, psychology experts at the University of Kentucky say you’re not alone.
A new University of Kentucky College of Medicine study will examine how policies that restrict the sale of flavored tobacco products including menthol cigarettes impact health disparities among vulnerable populations.
University of Kentucky Neuroscience Professor Greg Gerhardt's new research program will provide answers to long-standing questions about the role of neurotransmitters GABA and glutamate in the progression of Alzheimer’s disease. A culmination of his nearly 40 years of brain research, Gerhardt's study could help to develop new treatments for the disease.
Thanks to a $5.6 million grant from the NIH, a University of Kentucky College of Medicine team will study the culprit behind thoracic aortic aneurysms, which could lead to a treatment for the potentially deadly disease.
A new study by University of Kentucky researchers estimates the return to in-person learning in Texas last fall led to at least 43,000 additional COVID-19 cases and 800 deaths within the first two months.
A University of Kentucky College of Medicine professor has been awarded a $1.9 million NIH grant for his research on the body’s immune response to sepsis, which could potentially help to improve therapies for the common disease.
Collaborative research between the University of Kentucky (UK) and University of Southern California (USC) suggests that a noninvasive neuroimaging technique may index early-stage blood-brain barrier (BBB) dysfunction associated with small vessel disease (SVD).
The University of Kentucky is offering a web-based course this summer to help students hone important life skills to make the transition to adulthood easier. Adulting 101 is an eight-week summer course beginning on June 15 and meeting every Tuesday through Zoom. Organized by the UK College of Agriculture, Food and Environment and the UK Cooperative Extension Service, the course is open to teenagers nationwide, no matter their goals. Adulting 101 originated as a county-based family and consumer sciences extension program piloted in Central Kentucky.
The UK Markey Cancer Center will be the first site worldwide to initiate a cancer clinical trial that evaluates its anti-cancer activity in humans using ArtemiLife™ Inc. coffee products, which are made using the leaves of the Artemisia annua plant.
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
University of Kentucky announces the establishment of the world’s largest repository of American white oak as part of a groundbreaking effort with Maker’s Mark to conserve, explore and secure the future of American white oak. The repository hopes to transform conservation of a species critical to many American industries.
To learn more about the impact of COVID-19 on TV journalists, researchers in the College of Social Work (CoSW) Self-Care Lab at the University of Kentucky conducted a national study.
The discovery, published in Nature Materials, has potentially transformative consequences for the field.
After conducting a study to assess the need for cancer education materials in Appalachian Kentucky, members of the University of Kentucky Markey Cancer Center’s Appalachian Career Training in Oncology (ACTION) program worked with faculty from the UK College of Education to create a three-part cancer education curriculum for middle and high school teachers in the region.
A unique digital media study focused on educational equity issues surrounding Teach For America has been published by University of Kentucky College of Education Dean Julian Vasquez Heilig. The study is thought to be the first in educational policy to use a new form of research — digital ethnography — to analyze participant responses.
For the first time, a research team has obtained high resolution sedimentary core samples from Lake Tanganyika. The samples show that high frequency variability in climate can lead to major disruptions in how the lake's food web functions. The changes could put millions of people at risk who rely on the lake for food security. The team says the findings are a critical building block toward research-informed policymaking in the Lake Tanganyika region.
From the limited data currently available, Wilson, Hammer and Usher found that engineering students aren’t necessarily more likely to have a mental health concern, but they are significantly less likely to seek help than non-engineering college students. This treatment gap became the basis for their National Science Foundation (NSF) grant proposal titled, “Development of a Survey Instrument to Identify Mental Health Related Help-Seeking Beliefs in Engineering Students.”
Recent work published by researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) highlights what the lead investigator calls the “cornerstone” of her lab.
A new University of Kentucky College of Medicine study may provide answers for why so many COVID-19 patients experience thrombosis, or the formation of blood clots that obstruct blood flow through the circulatory system.
As the COVID-19 pandemic persists, children across the country are facing social isolation. With many school districts in the U.S. choosing remote learning, students are likely to consume more mass media. You might be wondering, should parents be concerned?
A new University of Kentucky College of Medicine study provides insight into how a protein called angiotensinogen contributes to blood pressure regulation and atherosclerosis.
The paper explains that current therapeutic approaches to the treatment of Alzheimer’s disease focus on the major pathological hallmarks of the disease which are amyloid plaques and neurofibrillary tangles. They are the requirements for a diagnosis of Alzheimer’s disease. However, the authors say there has been an explosion of genetic data suggesting the risk for sporadic Alzheimer’s disease is driven by several other factors including neuroinflammation, membrane turnover and storage, and lipid metabolism.
Working with their colleagues at the University of Pennsylvania, researchers at the University of Kentucky have found that they can differentiate between subtypes of dementia inducing brain disease. “For the first time we created criteria that could differentiate between frontotemporal dementia (FTD) and a common Alzheimer’s ‘mimic’ called LATE disease,” explained Dr. Peter Nelson of the Sanders-Brown Center on Aging at the University of Kentucky.
Coal-to-carbon fiber research shows great promise to positively impact the nation’s sluggish coal industry.
University of Kentucky researcher Nika Larian has been awarded a Science & Technology Policy Fellowship with the American Association for the Advancement of Science.
PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
Used as a medicinal herb for centuries, Artemisia annua contains powerful compounds that make it a popular treatment for malaria. But with lab research showing these compounds may help treat a variety of cancers and even COVID-19, this plant is more relevant than ever -- and UK is showing how we can take it from Kentucky fields to the research lab to our patients.
The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication. A monumental study in the field of dementia research is set to get underway in the coming weeks at UK.
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.
University of Kentucky virologist Rebecca Dutch answers key questions about SARS-CoV-2 and the coronavirus pandemic.
“When I first saw the text inside the scroll, it felt like I was a kid again — like digging through the sand for fossils at one of those museum exhibits and actually finding one. I was so excited,” Tamasi said. “I was the first person to see the contents of the scroll this millennium. There aren’t many opportunities like that.”
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.
The long-running study on aging and brain health at the University of Kentucky’s Sanders-Brown Center on Aging Alzheimer’s Disease Center has once again resulted in important new findings – highlighting a complex and under-recognized form of dementia.
The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.
Today, Juneteenth — which celebrates the abolition of slavery — coincides with protests across the U.S. against racial injustice. Society has become inspired to renew their interest in African American history — a legacy filled with tragedy, inequality, resilience and survival. In a Q&A session, UK's Vanessa Holden shares her expertise and insight on the holiday.
University of Kentucky College of Medicine researchers are using special antibodies made by alpacas to help understand COVID-19 and potentially develop a treatment that could protect people from being infected.
A study led by University of Kentucky Markey Cancer Center researchers showed that patients who already used opioids, sedatives or antidepressants prior to colorectal surgery experience significantly more complications post-surgery.
The University of Kentucky and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.
A new University of Kentucky Markey Cancer Center study finds that many Kentucky patients with colon cancer are not receiving the recommended standard of care therapy for their disease.
Research has shown African American women have disproportionately higher rates of cardiovascular disease risk factors compared to their white counterparts. UK College of Health Sciences assistant professor Brandi White has been working with African American women living in public housing on Lexington’s East End to develop culturally responsive strategies to overcome social and economic barriers to a heart-healthy lifestyle and reduce their cardiovascular disease risk.